Reviewing Clinical Therapy Advances and Management of Amyotrophic Lateral Sclerosis
This program will examine the pathophysiology and degenerative effects of amyotrophic lateral sclerosis (ALS).
Novel Advances in Hereditary ATTR Amyloidosis: Payer and Specialty Pharmacy Considerations
This program will analyze data supporting the use of current and emerging therapies for the treatment of hATTR.
Examining Therapy, Health Care Utilization, and Patient Management for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
This program will identify the cost and pharmacy benefit implications of CIDP care coordination in inpatient and outpatient settings.
An AJMC Supplement: Exploring Therapeutic Targets of the Beta Amyloid Pathway to Slow the Progression of Alzheimer Disease
The activity will investigate the role of therapies that target the beta amyloid pathway for the treatment of Alzheimer Disease.